Oppenheimer Oppenheimer Downgrades Invitae to Perform Rating Although Oppenheimer raised its price target from $48 to $51 in early January, the investment firm sees "increased risk of underperformance for Invitae shares." M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Although the total number of deals went down in 2020, those deals were worth more compared to 2019 — four of the top five had billion-dollar price tags. Oppenheimer Initiates Coverage of Bionano Genomics at Outperform The investment bank said the company's molecular diagnostics have the potential to replace microarrays for cytogenetics analysis. Bionano Genomics to Publicly Offer Securities, Amends Loan Agreement The genome mapping firm had fallen out of compliance with respect to its loan agreement with Innovatus and will prepay $5 million toward the loan principal. Bionano Genomics Prices $18M Public Offering Shares of firm fell 47 percent on the news it will sell 20.9 million common shares along with warrants to purchase up to the same number of shares. Jan 22, 2013 Analysts Speculate on Potential Life Technologies Sale Sep 4, 2012 Oppenheimer Bullish on Life Tech's Ion Proton Instrument as Anticipated Launch Nears Jan 13, 2012 Bank Ups Revenue Estimate on Sequenom Oct 5, 2011 Oppenheimer Starts Coverage of Genomic Health, Thermo Fisher Scientific, Fluidigm Sep 22, 2011 Oppenheimer Lowers EPS, Revenue Estimates for PacBio Following Layoffs Aug 26, 2011 Oppenheimer Analyst Calls Life Tech Shares Undervalued, Reiterates Outperform Rating Jul 21, 2011 Analyst: Sequenom to Hire 20 Sales Reps for T21 Test by End of August Jun 22, 2011 CMS Seeks Stakeholder Input on Gene Test Reimbursement, Maintains Code Stacking for 2012 Premium Apr 5, 2011 Oppenheimer Revises Revenue Estimates for Life Technologies Mar 18, 2011 Oppenheimer Initiates Coverage of Complete Genomics with 'Outperform' Rating Breaking News New Method Generates High-Resolution Transcriptome-Wide Spatial Gene Expression Maps GE Healthcare, University of Cambridge Team on AI-Based Precision Oncology Qiagen Sued for Allegedly Infringing Patent With Wi-Fi-Connected Instrument Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy Top Five Articles on GenomeWeb Last Week: Invitae, Beckman Coulter, Ancient DNA, and More Radiomics, OncoDNA Partner to ID Lung Cancer Biomarkers The Scan Omicron's Emergence The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes. Not as Much Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says. Bats That Hang Together Discover magazine writes that researchers have found a social microbiome among vampire bats. PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.